美国非小细胞肺癌死亡率的种族/种族差异,2000-2020年:基于人口的研究
Yuze Yin1, Yinyan Gao2, Hang Yi3
1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
QJM : monthly journal of the Association of Physicians
|January 8, 2026
概括
非小细胞肺癌 (NSCLC) 死亡率的种族差异仍然存在. 诊断阶段和收入等因素对这些不平等造成了重大影响,突显了针对性干预措施的必要性,以改善所有种族群体的结果.
科学领域:
- 在瘤学瘤学.
- 健康差距 研究 研究 研究 研究
- 流行病学 流行病学
背景情况:
- 非小细胞肺癌 (NSCLC) 是美国癌症死亡的主要原因.
- 在NSCLC的结果中存在已知的种族和民族差异,但长期趋势和促成因素需要进一步调查.
研究的目的:
- 分析长期 (2000-2020) 种族和种族差异的NSCLC死亡率.
- 评估临床和社会经济因素对这些差异的影响.
主要方法:
- 来自SEER数据库 (2000-2020) 的548,526名NSCLC患者的回顾性分析.
- 利用Fine和Gray模型和多变量回归来分析累积死亡发生率并量化贡献因素.
主要成果:
- 黑人患者的5年累计死亡率最高 (83.5%).
- 诊断时的阶段,针对癌症的手术和家庭收入对观察到的差异作出了重大贡献.
- 虽然相对差异减少了,但绝对差异扩大了,特别是在黑人和白人患者之间.
结论:
- 二十年来NSCLC死亡率持续存在的种族和民族差异凸显了持续的健康不平等.
- 解决晚期诊断问题和确保平等获得癌症治疗对于促进NSCLC护理中的健康公平至关重要.
相关概念视频
Statistical Methods for Analyzing Epidemiological Data
889
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
889
Bias in Epidemiological Studies
1.3K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.3K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Stereotypes, Prejudice, and Discrimination
94.9K
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
94.9K
Longitudinal Research
13.1K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.1K
Comparing the Survival Analysis of Two or More Groups
548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548


